STOCK TITAN
  1. Home
  2. Sec-filings
  3. CRWV
  4. [144] CoreWeave, Inc. SEC Filing

Large CRWV (NASDAQ: CRWV) insider and trust share sales detailed in Form 144

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

An affiliated holder of CRWV has filed a notice of proposed sale of 102,830 common shares, to be sold through Morgan Stanley Smith Barney LLC on the NASDAQ, with an aggregate market value of $9,582,727.70. These shares are part of founders’ shares originally acquired from the issuer on 02/25/2019. The filing notes that 386,401,201 common shares were outstanding when the notice was prepared. It also lists extensive recent Rule 10b5‑1 plan sales of CRWV common stock over the prior three months by Brannin McBee, multiple related trusts and entities, and a non‑affiliate donee, each with specified share amounts and gross proceeds.

Positive

  • None.

Negative

  • None.

Insights

Planned insider share sale and sizable recent 10b5‑1 selling activity, but no direct change to company finances.

This notice shows an affiliated holder planning to sell 102,830 CRWV common shares, valued at about $9.58M, on the NASDAQ through Morgan Stanley. The shares are founders’ stock acquired from the issuer on 02/25/2019, indicating long‑held insider ownership.

The table of prior three‑month activity details repeated Rule 10b5‑1 sales by Brannin McBee, several related trusts, GRATs, and a non‑affiliate donee, each with specified share counts and multi‑million‑dollar gross proceeds. Because these are secondary sales, cash flows go to the selling holders, not the company, so there is no direct balance‑sheet impact.

The filing is mainly informative about ownership changes and potential trading supply in CRWV shares. It does not provide new information on the issuer’s revenues, profits, operations, or outlook, and the signatory represents they are not aware of undisclosed material adverse information at the time of the plan or instruction.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR

FAQ

What does the latest Form 144 filing for CRWV disclose?

The filing discloses a planned sale of 102,830 CRWV common shares, with an aggregate market value of about $9,582,727.70, to be executed through Morgan Stanley Smith Barney LLC on the NASDAQ, using founders’ shares originally acquired in 2019.

How many CRWV shares are planned to be sold and what is their value?

The notice covers 102,830 CRWV common shares with an aggregate market value of approximately $9,582,727.70. These shares are scheduled for sale on the NASDAQ through Morgan Stanley Smith Barney LLC, according to the Rule 144 disclosure tables.

How many CRWV shares were outstanding when the Form 144 was prepared?

The document states that 386,401,201 CRWV common shares were outstanding when the notice was prepared. This figure provides context for the planned sale of 102,830 shares under Rule 144 but does not itself represent any new issuance or registered offering.

What is the origin of the CRWV shares being sold under Rule 144?

The shares are described as founders’ shares of CRWV common stock. They were acquired from the issuer on 02/25/2019, with the filing noting an acquisition of 102,830 securities on that date and classifying the transaction as “Founders Shares.”

Which broker and exchange are involved in the planned CRWV share sale?

The planned sale will be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, located in New York. The shares are to be sold on the NASDAQ exchange, with an approximate sale date listed as 02/02/2026 in the securities information table.

What recent 10b5-1 trading activity is disclosed for CRWV insiders and trusts?

The filing lists multiple Rule 10b5‑1 sales of CRWV common stock over the prior three months by Brannin McBee, various related trusts and GRATs, and a non‑affiliate donee. Each entry shows trade dates, share amounts, and gross proceeds in the hundreds of thousands to millions of dollars.